Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1715

1.

Antibodies to Peptides in Semiconserved Domains of RIFINs and STEVORs Correlate with Malaria Exposure.

Zhou AE, Berry AA, Bailey JA, Pike A, Dara A, Agrawal S, Stucke EM, Ouattara A, Coulibaly D, Lyke KE, Laurens MB, Adams M, Takala-Harrison S, Pablo J, Jasinskas A, Nakajima R, Niangaly A, Kouriba B, Kone AK, Rowe JA, Doumbo OK, Thera MA, Patel JJ, Tan JC, Felgner PL, Plowe CV, Travassos MA.

mSphere. 2019 Mar 20;4(2). pii: e00097-19. doi: 10.1128/mSphere.00097-19.

2.

How to apply the movement disorder society criteria for diagnosis of progressive supranuclear palsy.

Grimm MJ, Respondek G, Stamelou M, Arzberger T, Ferguson L, Gelpi E, Giese A, Grossman M, Irwin DJ, Pantelyat A, Rajput A, Roeber S, van Swieten JC, Troakes C, Antonini A, Bhatia KP, Colosimo C, van Eimeren T, Kassubek J, Levin J, Meissner WG, Nilsson C, Oertel WH, Piot I, Poewe W, Wenning GK, Boxer A, Golbe LI, Josephs KA, Litvan I, Morris HR, Whitwell JL, Compta Y, Corvol JC, Lang AE, Rowe JB, Höglinger GU; Movement Disorder Society-endorsed PSP Study Group.

Mov Disord. 2019 Mar 18. doi: 10.1002/mds.27666. [Epub ahead of print]

PMID:
30884545
3.

Proximity extension assay testing reveals novel diagnostic biomarkers of atypical parkinsonian syndromes.

Jabbari E, Woodside J, Guo T, Magdalinou NK, Chelban V, Athauda D, Lees AJ, Foltynie T, Houlden H, Church A, Hu MT, Rowe JB, Zetterberg H, Morris HR.

J Neurol Neurosurg Psychiatry. 2019 Mar 13. pii: jnnp-2018-320151. doi: 10.1136/jnnp-2018-320151. [Epub ahead of print]

4.

Cerebral perfusion changes in presymptomatic genetic frontotemporal dementia: a GENFI study.

Mutsaerts HJMM, Mirza SS, Petr J, Thomas DL, Cash DM, Bocchetta M, de Vita E, Metcalfe AWS, Shirzadi Z, Robertson AD, Tartaglia MC, Mitchell SB, Black SE, Freedman M, Tang-Wai D, Keren R, Rogaeva E, van Swieten J, Laforce R, Tagliavini F, Borroni B, Galimberti D, Rowe JB, Graff C, Frisoni GB, Finger E, Sorbi S, de Mendonça A, Rohrer JD, MacIntosh BJ, Masellis M; GENFI consortium .

Brain. 2019 Mar 7. pii: awz039. doi: 10.1093/brain/awz039. [Epub ahead of print]

PMID:
30847466
5.

In vivo evidence for pre-symptomatic neuroinflammation in a MAPT mutation carrier.

Bevan-Jones WR, Cope TE, Jones PS, Passamonti L, Hong YT, Fryer T, Arnold R, Coles JP, Aigbirhio FI, O'Brien JT, Rowe JB.

Ann Clin Transl Neurol. 2019 Jan 2;6(2):373-378. doi: 10.1002/acn3.683. eCollection 2019 Feb.

6.

Large incidental gastrointestinal stromal tumors in a patient presenting with acutely symptomatic nephrolithiasis: A case report.

Obinero C, Makar GS, Rowe JS, Makar MS, Holdbrook T, Hageboutros A, Spitz FR, Kovacs JE.

Radiol Case Rep. 2019 Feb 26;14(5):555-560. doi: 10.1016/j.radcr.2019.02.005. eCollection 2019 May.

7.

Multi-scale stochastic organization-oriented coarse-graining exemplified on the human mitotic checkpoint.

Henze R, Mu C, Puljiz M, Kamaleson N, Huwald J, Haslegrave J, di Fenizio PS, Parker D, Good C, Rowe JE, Ibrahim B, Dittrich P.

Sci Rep. 2019 Mar 7;9(1):3902. doi: 10.1038/s41598-019-40648-w.

8.

Prognostic importance of apathy in syndromes associated with frontotemporal lobar degeneration.

Lansdall CJ, Coyle-Gilchrist ITS, Vázquez Rodríguez P, Wilcox A, Wehmann E, Robbins TW, Rowe JB.

Neurology. 2019 Mar 6. pii: 10.1212/WNL.0000000000007249. doi: 10.1212/WNL.0000000000007249. [Epub ahead of print]

PMID:
30842292
9.

Liver and muscle glycogen oxidation and performance with dose variation of glucose-fructose ingestion during prolonged (3 h) exercise.

King AJ, O'Hara JP, Arjomandkhah NC, Rowe J, Morrison DJ, Preston T, King RFGJ.

Eur J Appl Physiol. 2019 Mar 6. doi: 10.1007/s00421-019-04106-9. [Epub ahead of print]

PMID:
30840136
10.

Functional network resilience to pathology in presymptomatic genetic frontotemporal dementia.

Rittman T, Borchert R, Jones S, van Swieten J, Borroni B, Galimberti D, Masellis M, Tartaglia MC, Graff C, Tagliavini F, Frisoni GB, Laforce R Jr, Finger E, Mendonça A, Sorbi S, Rohrer JD, Rowe JB; Genetic Frontotemporal Dementia Initiative (GENFI).

Neurobiol Aging. 2019 Jan 4;77:169-177. doi: 10.1016/j.neurobiolaging.2018.12.009. [Epub ahead of print]

11.

The impact of the graft-versus-leukemia effect on survival in acute lymphoblastic leukemia.

Yeshurun M, Weisdorf D, Rowe JM, Tallman MS, Zhang MJ, Wang HL, Saber W, de Lima M, Sandmaier BM, Uy G, Kamble RT, Cairo MS, Cooper BW, Cahn JY, Ganguly S, Camitta B, Verdonck LF, Dandoy C, Diaz MA, Savani BN, George B, Liesveld J, McGuirk J, Byrne M, Grunwald MR, Drobyski WR, Pulsipher MA, Abdel-Azim H, Prestidge T, Wieduwilt MJ, Martino R, Norkin M, Beitinjaneh A, Seo S, Nishihori T, Wirk B, Frangoul H, Bashey A, Mori S, Marks DI, Bachanova V.

Blood Adv. 2019 Feb 26;3(4):670-680. doi: 10.1182/bloodadvances.2018027003.

12.

Disease-informed brain mapping teaches important lessons about the human brain.

Dagher A, Lehéricy S, Rowe JB, Siebner HR.

Neuroimage. 2019 Feb 21. pii: S1053-8119(19)30136-3. doi: 10.1016/j.neuroimage.2019.02.040. [Epub ahead of print] No abstract available.

PMID:
30798013
13.

The Electronic Health Record: Documenting the Unique Contributions of Social Workers.

Rowe J, Rizzo VM, Guthrie D, Vail MR, Kang SY, Golden R.

Health Soc Work. 2019 Feb 23. pii: hlz006. doi: 10.1093/hsw/hlz006. [Epub ahead of print] No abstract available.

PMID:
30796826
14.

Quality Risk Management Framework: Guidance for Successful Implementation of Risk Management in Clinical Development.

Suprin M, Chow A, Pillwein M, Rowe J, Ryan M, Rygiel-Zbikowska B, Wilson KJ, Tomlin I.

Ther Innov Regul Sci. 2019 Jan;53(1):36-44. doi: 10.1177/2168479018817752.

PMID:
30789098
15.

Calm in the midst of cytokine storm: a collaborative approach to the diagnosis and treatment of hemophagocytic lymphohistiocytosis and macrophage activation syndrome.

Halyabar O, Chang MH, Schoettler ML, Schwartz MA, Baris EH, Benson LA, Biggs CM, Gorman M, Lehmann L, Lo MS, Nigrovic PA, Platt CD, Priebe GP, Rowe J, Sundel RP, Surana NK, Weinacht KG, Mann A, Yuen JC, Meleedy-Rey P, Starmer A, Banerjee T, Dedeoglu F, Degar BA, Hazen MM, Henderson LA.

Pediatr Rheumatol Online J. 2019 Feb 14;17(1):7. doi: 10.1186/s12969-019-0309-6.

16.

Imaging Tau, Neuroinflammation, and Aβ in Dementia With Lewy Bodies: A Deep-Phenotyping Case Report.

Mak E, Surendranathan A, Nicastro N, Aigbirhio F, Rowe J, O'Brien J.

Mov Disord Clin Pract. 2018 Nov 8;6(1):77-80. doi: 10.1002/mdc3.12689. eCollection 2019 Jan. No abstract available.

PMID:
30746421
17.

Somatosensory system integrity explains differences in treatment response after stroke.

Ingemanson ML, Rowe JR, Chan V, Wolbrecht ET, Reinkensmeyer DJ, Cramer SC.

Neurology. 2019 Mar 5;92(10):e1098-e1108. doi: 10.1212/WNL.0000000000007041. Epub 2019 Feb 6.

PMID:
30728310
18.

The inner fluctuations of the brain in presymptomatic Frontotemporal Dementia: The chronnectome fingerprint.

Premi E, Calhoun VD, Diano M, Gazzina S, Cosseddu M, Alberici A, Archetti S, Paternicò D, Gasparotti R, van Swieten J, Galimberti D, Sanchez-Valle R, Laforce R Jr, Moreno F, Synofzik M, Graff C, Masellis M, Tartaglia MC, Rowe J, Vandenberghe R, Finger E, Tagliavini F, de Mendonça A, Santana I, Butler C, Ducharme S, Gerhard A, Danek A, Levin J, Otto M, Frisoni G, Cappa S, Sorbi S, Padovani A, Rohrer JD, Borroni B; Genetic FTD Initiative, GENFI.

Neuroimage. 2019 Apr 1;189:645-654. doi: 10.1016/j.neuroimage.2019.01.080. Epub 2019 Feb 1.

19.

Eltrombopag treatment during induction chemotherapy for acute myeloid leukaemia: a randomised, double-blind, phase 2 study.

Frey N, Jang JH, Szer J, Illés Á, Kim HJ, Ram R, Chong BH, Rowe JM, Borisenkova E, Liesveld J, Winer ES, Cherfi A, Aslanis V, Ghaznawi F, Strickland S.

Lancet Haematol. 2019 Mar;6(3):e122-e131. doi: 10.1016/S2352-3026(18)30231-X. Epub 2019 Jan 29.

PMID:
30704923
20.

A Novel Supplementation Approach to Enhance Host Response to Sublingual Vaccination.

Rowe JC, Attia Z, Kim E, Cormet-Boyaka E, Boyaka PN.

Sci Rep. 2019 Jan 24;9(1):715. doi: 10.1038/s41598-018-36370-8.

21.

The relationship between clinical trial accrual volume and outcomes in acute myeloid leukemia: A SWOG/ECOG-ACRIN study (S0106 and E1900).

Medeiros BC, Othus M, Tallman MS, Sun Z, Fernandez HF, Rowe JM, Lazarus HM, Appelbaum FR, Luger SM, Litzow MR, Erba HP.

Leuk Res. 2019 Mar;78:29-33. doi: 10.1016/j.leukres.2019.01.007. Epub 2019 Jan 17.

PMID:
30673620
22.

Effects of early life stress on cocaine conditioning and AMPA receptor composition are sex-specific and driven by TNF.

Ganguly P, Honeycutt JA, Rowe JR, Demaestri C, Brenhouse HC.

Brain Behav Immun. 2019 Jan 14. pii: S0889-1591(18)30643-3. doi: 10.1016/j.bbi.2019.01.006. [Epub ahead of print]

PMID:
30654007
23.

PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia.

Gu Z, Churchman ML, Roberts KG, Moore I, Zhou X, Nakitandwe J, Hagiwara K, Pelletier S, Gingras S, Berns H, Payne-Turner D, Hill A, Iacobucci I, Shi L, Pounds S, Cheng C, Pei D, Qu C, Newman S, Devidas M, Dai Y, Reshmi SC, Gastier-Foster J, Raetz EA, Borowitz MJ, Wood BL, Carroll WL, Zweidler-McKay PA, Rabin KR, Mattano LA, Maloney KW, Rambaldi A, Spinelli O, Radich JP, Minden MD, Rowe JM, Luger S, Litzow MR, Tallman MS, Racevskis J, Zhang Y, Bhatia R, Kohlschmidt J, Mrózek K, Bloomfield CD, Stock W, Kornblau S, Kantarjian HM, Konopleva M, Evans WE, Jeha S, Pui CH, Yang J, Paietta E, Downing JR, Relling MV, Zhang J, Loh ML, Hunger SP, Mullighan CG.

Nat Genet. 2019 Feb;51(2):296-307. doi: 10.1038/s41588-018-0315-5. Epub 2019 Jan 14.

PMID:
30643249
24.

The Shady Pink Elephant: End of Life Education for Young Women Affected by Breast Cancer.

Rowe J, Schapmire T.

J Cancer Educ. 2018 Dec 27. doi: 10.1007/s13187-018-1446-1. [Epub ahead of print]

PMID:
30591991
25.

Shifting therapeutic paradigms in induction and consolidation for older adults with acute myeloid leukemia.

Zuckerman T, Rowe JM.

Curr Opin Hematol. 2019 Mar;26(2):51-57. doi: 10.1097/MOH.0000000000000480.

PMID:
30585895
26.

Neuroticism predicts the impact of serotonin challenges on fear processing in subgenual anterior cingulate cortex.

Hornboll B, Macoveanu J, Nejad A, Rowe J, Elliott R, Knudsen GM, Siebner HR, Paulson OB.

Sci Rep. 2018 Dec 17;8(1):17889. doi: 10.1038/s41598-018-36350-y.

27.

Spatiotemporal analysis for detection of pre-symptomatic shape changes in neurodegenerative diseases: Initial application to the GENFI cohort.

Cury C, Durrleman S, Cash DM, Lorenzi M, Nicholas JM, Bocchetta M, van Swieten JC, Borroni B, Galimberti D, Masellis M, Tartaglia MC, Rowe JB, Graff C, Tagliavini F, Frisoni GB, Laforce R Jr, Finger E, de Mendonça A, Sorbi S, Ourselin S, Rohrer JD, Modat M; Genetic FTD Initiative, GENFI.

Neuroimage. 2019 Mar;188:282-290. doi: 10.1016/j.neuroimage.2018.11.063. Epub 2018 Dec 6.

28.

Evaluation of an elective course for preparing students to pursue postgraduate residency training.

Hammond DA, Rowe JM, Wiley TL, Painter JT.

Curr Pharm Teach Learn. 2018 Sep;10(9):1264-1271. doi: 10.1016/j.cptl.2018.06.007. Epub 2018 Jun 28.

PMID:
30497630
29.

Representative Scale-Down Lyophilization Cycle Development Using a Seven-Vial Freeze-Dryer (MicroFD®).

Goldman JM, Chen X, Register JT, Nesarikar V, Iyer L, Wu Y, Mugheirbi N, Rowe J.

J Pharm Sci. 2019 Apr;108(4):1486-1495. doi: 10.1016/j.xphs.2018.11.018. Epub 2018 Nov 20.

PMID:
30468831
30.

Publisher Correction: Sensory attenuation in Parkinson's disease is related to disease severity and dopamine dose.

Wolpe N, Zhang J, Nombela C, Ingram JN, Wolpert DM; Cam-CAN, Rowe JB.

Sci Rep. 2018 Nov 22;8(1):17429. doi: 10.1038/s41598-018-35439-8.

31.

Extramedullary acute myeloid leukemia presenting in young adults demonstrates sensitivity to high dose anthracycline: subset analysis from ECOG-ACRIN 1900.

Fernandez HF, Sun Z, Litzow MR, Luger SM, Paietta E, Racevskis J, Levine RL, Patel JP, Abdel-Wahab O, Ketterling RP, Dewald GW, Bennett JM, Rowe JM, Lazarus HM, Tallman MS.

Haematologica. 2018 Nov 22. pii: haematol.2018.197277. doi: 10.3324/haematol.2018.197277. [Epub ahead of print]

32.

Progress and predictions: AML in 2018.

Rowe JM.

Best Pract Res Clin Haematol. 2018 Dec;31(4):337-340. doi: 10.1016/j.beha.2018.09.002. Epub 2018 Sep 20. Review.

PMID:
30466743
33.

The role of dopamine in the brain - lessons learned from Parkinson's disease.

Meder D, Herz DM, Rowe JB, Lehéricy S, Siebner HR.

Neuroimage. 2018 Nov 20. pii: S1053-8119(18)32092-5. doi: 10.1016/j.neuroimage.2018.11.021. [Epub ahead of print] Review.

34.

Directly Measuring the Rate of Slacking as Stroke Survivors produced Isometric Forces during a Tracking Task.

Smith BW, Rowe JB, Reinkensmeyer DJ.

Conf Proc IEEE Eng Med Biol Soc. 2018 Jul;2018:2519-2522. doi: 10.1109/EMBC.2018.8512740.

PMID:
30440920
35.

Right Ventricular Outflow Obstruction Due to Metastatic Neuroendocrine Tumor.

Sood A, Chiadika SM, Everett JM, Au J, Rowe J.

Cureus. 2018 Sep 6;10(9):e3261. doi: 10.7759/cureus.3261.

36.

In vivo coupling of tau pathology and cortical thinning in Alzheimer's disease.

Mak E, Bethlehem RAI, Romero-Garcia R, Cervenka S, Rittman T, Gabel S, Surendranathan A, Bevan-Jones RW, Passamonti L, Vázquez Rodríguez P, Su L, Arnold R, Williams GB, Hong YT, Fryer TD, Aigbirhio FI, Rowe JB, O'Brien JT.

Alzheimers Dement (Amst). 2018 Sep 17;10:678-687. doi: 10.1016/j.dadm.2018.08.005. eCollection 2018.

37.

Strong and specific associations between cardiovascular risk factors and white matter micro- and macrostructure in healthy aging.

Fuhrmann D, Nesbitt D, Shafto M, Rowe JB, Price D, Gadie A; Cam-CAN, Kievit RA.

Neurobiol Aging. 2019 Feb;74:46-55. doi: 10.1016/j.neurobiolaging.2018.10.005. Epub 2018 Oct 12.

38.

Early microglial activation and peripheral inflammation in dementia with Lewy bodies.

Surendranathan A, Su L, Mak E, Passamonti L, Hong YT, Arnold R, Vázquez Rodríguez P, Bevan-Jones WR, Brain SAE, Fryer TD, Aigbirhio FI, Rowe JB, O'Brien JT.

Brain. 2018 Dec 1;141(12):3415-3427. doi: 10.1093/brain/awy265.

39.

Myeloablative vs reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chronic myeloid leukemia.

Chhabra S, Ahn KW, Hu ZH, Jain S, Assal A, Cerny J, Copelan EA, Daly A, DeFilipp Z, Gadalla SM, Gale RP, Ganguly S, Hamilton BK, Hildebrandt GC, Hsu JW, Inamoto Y, Kanate AS, Khoury HJ, Lazarus HM, Litzow MR, Nathan S, Olsson RF, Pawarode A, Ringden O, Rowe JM, Saad A, Savani BN, Schouten HC, Seo S, Shah NN, Solh M, Stuart RK, Ustun C, Woolfrey AE, Yared JA, Alyea EP, Kalaycio ME, Popat U, Sobecks RM, Saber W.

Blood Adv. 2018 Nov 13;2(21):2922-2936. doi: 10.1182/bloodadvances.2018024844.

40.

Squamous cell carcinoma arising in a partially ruptured giant mature cystic teratoma: A case report.

Rowe JS, Makar G, Holdbrook T, Germaine P.

Radiol Case Rep. 2018 Oct 24;14(1):97-102. doi: 10.1016/j.radcr.2018.09.029. eCollection 2019 Jan.

41.

A randomized trial of three novel regimens for recurrent acute myeloid leukemia demonstrates the continuing challenge of treating this difficult disease.

Litzow MR, Wang XV, Carroll MP, Karp JE, Ketterling RP, Zhang Y, Kaufmann SH, Lazarus HM, Luger SM, Paietta EM, Pratz KW, Tun HW, Altman JK, Broun ER, Rybka WB, Rowe JM, Tallman MS.

Am J Hematol. 2019 Jan;94(1):111-117. doi: 10.1002/ajh.25333. Epub 2018 Nov 15.

PMID:
30370956
42.

Landscape Analysis of a Class of NP-Hard Binary Packing Problems.

Alyahya K, Rowe JE.

Evol Comput. 2019 Spring;27(1):47-73. doi: 10.1162/evco_a_00237. Epub 2018 Oct 26.

PMID:
30365387
43.

Relative skeletal distribution of proliferating marrow in the adult dog determined using 3'-deoxy-3'-[18 F]fluorothymidine.

Rowe JA, Morandi F, Osborne DR, Wall JS, Kennel SJ, Reed RB, LeBlanc AK.

Anat Histol Embryol. 2019 Jan;48(1):46-52. doi: 10.1111/ahe.12410. Epub 2018 Oct 23.

PMID:
30353574
44.

Sensory attenuation in Parkinson's disease is related to disease severity and dopamine dose.

Wolpe N, Zhang J, Nombela C, Ingram JN, Wolpert DM; Cam-CAN, Rowe JB.

Sci Rep. 2018 Oct 23;8(1):15643. doi: 10.1038/s41598-018-33678-3. Erratum in: Sci Rep. 2018 Nov 22;8(1):17429.

45.

[18F]AV-1451 binding is increased in frontotemporal dementia due to C9orf72 expansion.

Bevan-Jones RW, Cope TE, Jones SP, Passamonti L, Hong YT, Fryer T, Arnold R, Coles JP, Aigbirhio FA, Patterson K, O'Brien JT, Rowe JB.

Ann Clin Transl Neurol. 2018 Sep 14;5(10):1292-1296. doi: 10.1002/acn3.631. eCollection 2018 Oct.

46.

Predict Disease Progression With Reaction Rate Equation Modeling of Multimodal MRI and PET.

Su L, Huang Y, Wang Y, Rowe J, O'Brien J.

Front Aging Neurosci. 2018 Oct 8;10:306. doi: 10.3389/fnagi.2018.00306. eCollection 2018.

47.

Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference.

Young AL, Marinescu RV, Oxtoby NP, Bocchetta M, Yong K, Firth NC, Cash DM, Thomas DL, Dick KM, Cardoso J, van Swieten J, Borroni B, Galimberti D, Masellis M, Tartaglia MC, Rowe JB, Graff C, Tagliavini F, Frisoni GB, Laforce R Jr, Finger E, de Mendonça A, Sorbi S, Warren JD, Crutch S, Fox NC, Ourselin S, Schott JM, Rohrer JD, Alexander DC; Genetic FTD Initiative (GENFI); Alzheimer’s Disease Neuroimaging Initiative (ADNI).

Nat Commun. 2018 Oct 15;9(1):4273. doi: 10.1038/s41467-018-05892-0.

48.

Dissociable effects of acute SSRI (escitalopram) on executive, learning and emotional functions in healthy humans.

Skandali N, Rowe JB, Voon V, Deakin JB, Cardinal RN, Cormack F, Passamonti L, Bevan-Jones WR, Regenthal R, Chamberlain SR, Robbins TW, Sahakian BJ.

Neuropsychopharmacology. 2018 Dec;43(13):2645-2651. doi: 10.1038/s41386-018-0229-z. Epub 2018 Sep 26.

49.

Are professional young rugby league players eating enough? Energy intake, expenditure and balance during a pre-season.

Costello N, Deighton K, Preston T, Matu J, Rowe J, Jones B.

Eur J Sport Sci. 2019 Feb;19(1):123-132. doi: 10.1080/17461391.2018.1527950. Epub 2018 Oct 7.

PMID:
30293523
50.

Predictors for a dementia gene mutation based on gene-panel next-generation sequencing of a large dementia referral series.

Koriath C, Kenny J, Adamson G, Druyeh R, Taylor W, Beck J, Quinn L, Mok TH, Dimitriadis A, Norsworthy P, Bass N, Carter J, Walker Z, Kipps C, Coulthard E, Polke JM, Bernal-Quiros M, Denning N, Thomas R, Raybould R, Williams J, Mummery CJ, Wild EJ, Houlden H, Tabrizi SJ, Rossor MN, Hummerich H, Warren JD, Rowe JB, Rohrer JD, Schott JM, Fox NC, Collinge J, Mead S.

Mol Psychiatry. 2018 Oct 2. doi: 10.1038/s41380-018-0224-0. [Epub ahead of print]

PMID:
30279455

Supplemental Content

Support Center